Civic Intelligence

Testicular Cancer Commons

990EZ • Fiscal year 2017 • EIN 45-4798068

Jan 01, 2017 to Dec 31, 2017 • Filed on Jun 06, 2018

Organization ProfileTESTICULARCANCERCOMMONS.ORG
3100 SE 168th No 7Vancouver, WA 98683

(503) 997-8632

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Net Margin

96th percentile

76%

Higher net margin than 96% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Asset Growth

91st percentile

97%

Faster asset growth than 91% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Revenue Growth

88th percentile

63%

Faster revenue growth than 88% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets56th percentile

Assets

Up

$134,222

Up $66,080 (+97%) from 2016

Net Assets

Up

$134,222

Up $66,080 (+97%) from 2016

Liabilities

Flat

$0

Flat from 2016

Revenue And Expenses
Liabilities / Revenue56th percentileNet Margin96th percentile

Revenue

Up

$87,372

Up $33,681 (+63%) from 2016

Expenses

Up

$21,292

Up $14,909 (+234%) from 2016

Net Income

Up

$66,080

Up $18,772 (+40%) from 2016

Historical Trend

Balance Sheet Trend

Asset Growth91st percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200K$150K$100K$50K$0Assets 2013: $5,202Liabilities 2013: $02013Assets 2014: $11,443Liabilities 2014: $0Net Assets 2014: $11,4432014Assets 2015: $20,834Liabilities 2015: $0Net Assets 2015: $20,8342015Assets 2016: $68,142Liabilities 2016: $0Net Assets 2016: $68,1422016Assets 2017: $134,222Liabilities 2017: $0Net Assets 2017: $134,2222017Assets 2018: $111,197Net Assets 2018: $111,1972018Assets 2019: $98,114Net Assets 2019: $98,1142019Assets 2020: $171,278Net Assets 2020: $171,2782020Assets 2021: $70,862Net Assets 2021: $70,8622021Assets 2022: $9,329Net Assets 2022: $9,3292022Assets 2023: $8,256Net Assets 2023: $8,2562023Assets 2024: $8,209Net Assets 2024: $8,2092024

Highlighted filing

2017

Assets$134,222
Liabilities$0
Net Assets$134,222
Open 2017 Filing

Operations Trend

Revenue Growth88th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100K-$200KRevenue 2013: $18,000Expenses 2013: $1,938Net Income 2013: $16,0622013Revenue 2014: $16,084Expenses 2014: $9,844Net Income 2014: $6,2402014Revenue 2015: $26,319Expenses 2015: $14,928Net Income 2015: $11,3912015Revenue 2016: $53,691Expenses 2016: $6,383Net Income 2016: $47,3082016Revenue 2017: $87,372Expenses 2017: $21,292Net Income 2017: $66,0802017Revenue 2018: $92,591Expenses 2018: $115,616Net Income 2018: -$23,0252018Revenue 2019: $153,615Expenses 2019: $166,698Net Income 2019: -$13,0832019Revenue 2020: $137,047Expenses 2020: $63,883Net Income 2020: $73,1642020Revenue 2021: $139,298Expenses 2021: $239,714Net Income 2021: -$100,4162021Revenue 2022: $26,493Expenses 2022: $88,026Net Income 2022: -$61,5332022Revenue 2023: $22,569Expenses 2023: $23,642Net Income 2023: -$1,0732023Revenue 2024: $24,649Expenses 2024: $24,686Net Income 2024: -$372024

Highlighted filing

2017

Revenue$87,372
Expenses$21,292
Net Income$66,080
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Jun 6, 2018
Return Version
2017v2.2
Gross Receipts
$87,372
Mission and Program Overview

Mission

The specific purpose of testicular cancer commons is to provide a patient-centered source for the exchange of information and knowledge for testicular cancer and to facilitate expert-based clinical decision support, patient education and large database research.its vision is to preserve and improve the lives of cancer patients by transforming patient engagement and patient-centered decision-making in cancer care.the organization enacts its vision through it's mission - to improve and personalize the care and decision making in cancer across geographic and business boundaries by aggregating, in real time, comprehensive actionable patient- and provider-supplied clinical information for patients with cancer by:- influencing positively clinical outcomes and costs by making personalized, real-time, knowledge-enriched cancer decisions- generating research-quality clinical and biological data sets for cancer in a patient-centered and patient-controlled environment- learning systematically fro

Program Services

DescriptionGrantsExpenses
SCIENTIFIC CONTRIBUTIONS TO TESTICULAR CANCER KNOWLEDGE BASE IN THE FORM OF SCIENTIFIC COLLABORATIONS TO INITIATE AND FACILITATE PROJECTS AND PUBLICATIONS. TESTICULAR CANCER COMMONS HAS LED OR CO-LEADS A NUMBER OF SCIENTIFIC PROJECTS THAT HAVE LED TO OVER 15 PEER REVIEWED PUBLICATIONS AND PRESENTATIONS SINCE 2012.A MAJORITY OF THE PROGRAM SERVICE ACCOMPLISHMENTS MADE BY TESTICULAR CANCER COMMONS ARE ACHIEVED THROUGH THE DONATION OF TIME AND EXPERTISE BY DR. NICHOLS AND OTHER EXPERIENCED MEDICAL PROFESSIONALS INCLUDING TRAVEL AND PREPARATION OF POSTERS AND PAPERS SUBMITTED.$0$10,256
TESTICULAR CANCER COMMONS CONSIDERS THE FOLLOWING ACTIVITIES SIGNIFICANT PROGRAM SERVICE ACCOMPLISHMENTS, ALTHOUGH NO CASH EXPENDITURES CAN BE SPECIFICALLY ATTRIBUTED TO THESE ACTIVITIES FOR THE YEAR ENDED DECEMBER 31, 2017:1.) TESTICULAR COMMONS HAS BEEN SELECTED BY THE US MEDICAL ONCOLOGY PROFESSIONAL ORGANIZATION, THE AMERICAN SOCIETY OF MEDICAL ONCOLOGY (ASCO) TO DEVELOP AND DISTRIBUTE GUIDELINES FOR TESTICULAR CANCER. TESTICULAR CANCER COMMONS WILL LEAD THE EFFORT AND BE JOINED BY EUROPEAN, CANADIAN AND AUSTRALIAN PARTNERS. THE FIRST MEETING OF THE STEERING COMMITTEE WAS HELD IN CHICAGO IN LATE 2015.THE ASCO PROVIDED $87,372 IN INSTITUTIONAL SUPPORT OF ORGANIZATION'S ACTIVITIES SUCH AS FOR INFORMATICS AND SCIENTIFIC EFFORTS AND TRAVELS AND MEETINGS WITH BOARD DURING 2017. THE ORGANIZATION EXPECTS SUPPORT FROM ASCO TO END DURING 2018. 2.) TESTICULAR CANCER COMMONS HAS BEEN NAMED AS ONE OF THE PARTNERS IN THE WESTERN STATES' TESTICULAR CANCER CONSORTIUM, TO BUILD REAL TIME INFORMATION AND KNOWLEDGE EXCHANGE IN TESTICULAR CANCER. THE CONSORTIUM CONSISTS OF STANFORD UNIVERSITY, INTERMOUNTAIN MEDICAL CENTER AND TESTICULAR CANCER COMMONS. RECENT PROJECTS INCLUDE TELEHEALTH SOLUTIONS FOR TRANSFER OF EXPERIENCE AND KNOWLEDGE IN THE WESTERN UNITED STATES. 3.) TESTICULAR CANCER COMMONS IS ONE OF THE WORLD'S LEADERS IN SOCIAL MEDIA IN TESTIS CANCER AND HAS VERY ACTIVE TWITTER FEEDS AND FACEBOOK FEEDS TO HELP DISSEMINATE INFORMATION AND EXPERIENCE FOR PEOPLE WITH TESTICULAR CANCER. THE EXPENSES FOR THE SOCIAL MEDIA PROGRAM WERE ABSORBED AT THE BEGINNING OF THE ORGANIZATION WITH THE DESIGN OF THE WEBSITE AND LOGO. 4.) TESTICULAR CANCER COMMONS DIRECTOR CRAIG NICHOLS HAS WORKED WITH SWOG, ONE OF THE FIVE FEDERALLY SPONSORED CANCER COOPERATIVE RESEARCH GROUPS, TO DEVELOP AN INTERNATIONAL PROTOCOL INCORPORATING A NEW MOLECULAR BIOMARKER (MIRNA 371) INTO THE CARE AND DECISION MAKING IN EARLY STAGE TESTICULAR CANCER. TESTICULAR CANCER COMMONS ALSO REGULARLY CONTRIBUTES TO THE MIRNA 371 DATA CONSORTIUM. ONE OF DR. NICHOLS MENTEES, DR. LUCIA NAPPI FROM THE BRITISH COLUMBIA CANCER AGENCY WAS AWARDED A SPOT IN THE SWOG PRESTIGIOUS AND COMPETITIVE YOUNG INVESTIGATOR COURSE FOR HER WORK ON THIS PROJECT. 5.) OTHER ONGOING PROJECTS: - ORGANIZING MEETING REGARDING DATA PHILANTHROPY FROM INDIANA UNIVERSITY FOR SURGICAL, PATHOLOGY AND MEDICAL ONCOLOGY DATA BASES FOR GERM CELL TUMORS.- ENABLING TELEHEALTH SOLUTIONS FOR TRANSFER OF EXPERIENCE AND KNOWLEDGE IN THE WESTERN UNITED STATES.- CONTRIBUTIONS TO THE MIRNA IN GERM CELL TUMOR DATA CONSORTIUM.$0$0
Compensation and Service Providers
Top Officer Pay76th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
CRAIG R NICHOLS MDCEO & DirectorPT$0--
BRANDON HAYES-LATTIN MDScientific Director-$0--
CHRISTIAN KOLLMANNSBERGER MDScientific Director-$0--
DANE NICHOLSMDScientific Director-$0--
CHARLES LOPEZ MDScientific Director-$0--
Filing and Contact Details

Filer

Filer Name
Testicular Cancer Commons
EIN
45-4798068
Phone
5039978632
Address
3100 SE 168TH NO 7, VANCOUVER, WA 98683

Signing Officer

Name
Craig R Nichols
Title
Md
Phone
5039978632
Signed
2018-06-06
Discuss with paid preparer
Yes

Preparer

Firm
Dilorenzo & Company LLC
Address
10300 SW GREENBURG RD SUITE 360, PORTLAND, OR 97223
Preparer
Kripa Raguram
Phone
5036466696
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16 - Other Expenses

“Description: travel to conventions,seminars,board meetings,scientific programs. Amount: 5,770. Description: printing, postage & supplies . Amount: 2,537. Description: business meals . Amount: 1,647. Description: dues, suscriptions & memberships. Amount: 2,838. Total to form 990-ez, line 16: 12,792.”

Raw XML Appendix148 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/AddressChangeInd0X
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0CRAIG R NICHOLS
IRS990EZ/BooksInCareOfDetail/PhoneNum05039978632
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt03100 SE 168TH APT 7
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0VANCOUVER
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd098683
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt068142
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0134222
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt087372
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt066080
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt08500
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt068142
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0134222
IRS990EZ/GrossReceiptsAmt087372
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt068142
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0134222
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt068142
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0134222
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt022.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt23.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.04
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.04
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0CRAIG R NICHOLS MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1BRANDON HAYES-LATTIN MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2CHRISTIAN KOLLMANNSBERGER MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DANE NICHOLSMD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4CHARLES LOPEZ MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CEO & DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1SCIENTIFIC DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2SCIENTIFIC DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SCIENTIFIC DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4SCIENTIFIC DIRECTOR
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt012792
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0THE SPECIFIC PURPOSE OF TESTICULAR CANCER COMMONS IS TO PROVIDE A PATIENT-CENTERED SOURCE FOR THE EXCHANGE OF INFORMATION AND KNOWLEDGE FOR TESTICULAR CANCER AND TO FACILITATE EXPERT-BASED CLINICAL DECISION SUPPORT, PATIENT EDUCATION AND LARGE DATABASE RESEARCH.ITS VISION IS TO PRESERVE AND IMPROVE THE LIVES OF CANCER PATIENTS BY TRANSFORMING PATIENT ENGAGEMENT AND PATIENT-CENTERED DECISION-MAKING IN CANCER CARE.THE ORGANIZATION ENACTS ITS VISION THROUGH IT'S MISSION - TO IMPROVE AND PERSONALIZE THE CARE AND DECISION MAKING IN CANCER ACROSS GEOGRAPHIC AND BUSINESS BOUNDARIES BY AGGREGATING, IN REAL TIME, COMPREHENSIVE ACTIONABLE PATIENT- AND PROVIDER-SUPPLIED CLINICAL INFORMATION FOR PATIENTS WITH CANCER BY:- INFLUENCING POSITIVELY CLINICAL OUTCOMES AND COSTS BY MAKING PERSONALIZED, REAL-TIME, KNOWLEDGE-ENRICHED CANCER DECISIONS- GENERATING RESEARCH-QUALITY CLINICAL AND BIOLOGICAL DATA SETS FOR CANCER IN A PATIENT-CENTERED AND PATIENT-CONTROLLED ENVIRONMENT- LEARNING SYSTEMATICALLY FRO
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0SCIENTIFIC CONTRIBUTIONS TO TESTICULAR CANCER KNOWLEDGE BASE IN THE FORM OF SCIENTIFIC COLLABORATIONS TO INITIATE AND FACILITATE PROJECTS AND PUBLICATIONS. TESTICULAR CANCER COMMONS HAS LED OR CO-LEADS A NUMBER OF SCIENTIFIC PROJECTS THAT HAVE LED TO OVER 15 PEER REVIEWED PUBLICATIONS AND PRESENTATIONS SINCE 2012.A MAJORITY OF THE PROGRAM SERVICE ACCOMPLISHMENTS MADE BY TESTICULAR CANCER COMMONS ARE ACHIEVED THROUGH THE DONATION OF TIME AND EXPERTISE BY DR. NICHOLS AND OTHER EXPERIENCED MEDICAL PROFESSIONALS INCLUDING TRAVEL AND PREPARATION OF POSTERS AND PAPERS SUBMITTED.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1TESTICULAR CANCER COMMONS CONSIDERS THE FOLLOWING ACTIVITIES SIGNIFICANT PROGRAM SERVICE ACCOMPLISHMENTS, ALTHOUGH NO CASH EXPENDITURES CAN BE SPECIFICALLY ATTRIBUTED TO THESE ACTIVITIES FOR THE YEAR ENDED DECEMBER 31, 2017:1.) TESTICULAR COMMONS HAS BEEN SELECTED BY THE US MEDICAL ONCOLOGY PROFESSIONAL ORGANIZATION, THE AMERICAN SOCIETY OF MEDICAL ONCOLOGY (ASCO) TO DEVELOP AND DISTRIBUTE GUIDELINES FOR TESTICULAR CANCER. TESTICULAR CANCER COMMONS WILL LEAD THE EFFORT AND BE JOINED BY EUROPEAN, CANADIAN AND AUSTRALIAN PARTNERS. THE FIRST MEETING OF THE STEERING COMMITTEE WAS HELD IN CHICAGO IN LATE 2015.THE ASCO PROVIDED $87,372 IN INSTITUTIONAL SUPPORT OF ORGANIZATION'S ACTIVITIES SUCH AS FOR INFORMATICS AND SCIENTIFIC EFFORTS AND TRAVELS AND MEETINGS WITH BOARD DURING 2017. THE ORGANIZATION EXPECTS SUPPORT FROM ASCO TO END DURING 2018. 2.) TESTICULAR CANCER COMMONS HAS BEEN NAMED AS ONE OF THE PARTNERS IN THE WESTERN STATES' TESTICULAR CANCER CONSORTIUM, TO BUILD REAL TIME INFORMATION AND KNOWLEDGE EXCHANGE IN TESTICULAR CANCER. THE CONSORTIUM CONSISTS OF STANFORD UNIVERSITY, INTERMOUNTAIN MEDICAL CENTER AND TESTICULAR CANCER COMMONS. RECENT PROJECTS INCLUDE TELEHEALTH SOLUTIONS FOR TRANSFER OF EXPERIENCE AND KNOWLEDGE IN THE WESTERN UNITED STATES. 3.) TESTICULAR CANCER COMMONS IS ONE OF THE WORLD'S LEADERS IN SOCIAL MEDIA IN TESTIS CANCER AND HAS VERY ACTIVE TWITTER FEEDS AND FACEBOOK FEEDS TO HELP DISSEMINATE INFORMATION AND EXPERIENCE FOR PEOPLE WITH TESTICULAR CANCER. THE EXPENSES FOR THE SOCIAL MEDIA PROGRAM WERE ABSORBED AT THE BEGINNING OF THE ORGANIZATION WITH THE DESIGN OF THE WEBSITE AND LOGO. 4.) TESTICULAR CANCER COMMONS DIRECTOR CRAIG NICHOLS HAS WORKED WITH SWOG, ONE OF THE FIVE FEDERALLY SPONSORED CANCER COOPERATIVE RESEARCH GROUPS, TO DEVELOP AN INTERNATIONAL PROTOCOL INCORPORATING A NEW MOLECULAR BIOMARKER (MIRNA 371) INTO THE CARE AND DECISION MAKING IN EARLY STAGE TESTICULAR CANCER. TESTICULAR CANCER COMMONS ALSO REGULARLY CONTRIBUTES TO THE MIRNA 371 DATA CONSORTIUM. ONE OF DR. NICHOLS MENTEES, DR. LUCIA NAPPI FROM THE BRITISH COLUMBIA CANCER AGENCY WAS AWARDED A SPOT IN THE SWOG PRESTIGIOUS AND COMPETITIVE YOUNG INVESTIGATOR COURSE FOR HER WORK ON THIS PROJECT. 5.) OTHER ONGOING PROJECTS: - ORGANIZING MEETING REGARDING DATA PHILANTHROPY FROM INDIANA UNIVERSITY FOR SURGICAL, PATHOLOGY AND MEDICAL ONCOLOGY DATA BASES FOR GERM CELL TUMORS.- ENABLING TELEHEALTH SOLUTIONS FOR TRANSFER OF EXPERIENCE AND KNOWLEDGE IN THE WESTERN UNITED STATES.- CONTRIBUTIONS TO THE MIRNA IN GERM CELL TUMOR DATA CONSORTIUM.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt010256
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt10
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0OR
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt021292
IRS990EZ/TotalProgramServiceExpensesAmt010256
IRS990EZ/TotalRevenueAmt087372
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTP://TESTICULARCANCERCOMMONS.ORG/
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0SEATTLE
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm1INDIANAPOLIS
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm2BRITISH COLUMBIA
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm3SALT LAKE CITY
IRS990ScheduleA/HospitalNameAndAddressGrp/CountryCd0CA
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0WA
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd1IN
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd2UT
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0VIRGINIA MASON MEDICAL CENTER
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt1INDIANA UNIVERSITY MELVIN & BREN SIMON CANCER CENTER
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt2BRITISH COLUMBIA CANCER AGENCY
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt3INTERMOUNTAIN MEDICAL CENTER
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: TRAVEL TO CONVENTIONS,SEMINARS,BOARD MEETINGS,SCIENTIFIC PROGRAMS. AMOUNT: 5,770. DESCRIPTION: PRINTING, POSTAGE & SUPPLIES . AMOUNT: 2,537. DESCRIPTION: BUSINESS MEALS . AMOUNT: 1,647. DESCRIPTION: DUES, SUSCRIPTIONS & MEMBERSHIPS. AMOUNT: 2,838. TOTAL TO FORM 990-EZ, LINE 16: 12,792.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02018-06-14 16:35:46Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0CRAIG R NICHOLS
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0MD
ReturnHeader/BusinessOfficerGrp/PhoneNum05039978632
ReturnHeader/BusinessOfficerGrp/SignatureDt02018-06-06
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0TESTICULAR CANCER COMMONS
ReturnHeader/Filer/BusinessNameControlTxt0TEST
ReturnHeader/Filer/EIN0454798068
ReturnHeader/Filer/PhoneNum05039978632
ReturnHeader/Filer/USAddress/AddressLine1Txt03100 SE 168TH NO 7
ReturnHeader/Filer/USAddress/CityNm0VANCOUVER
ReturnHeader/Filer/USAddress/StateAbbreviationCd0WA
ReturnHeader/Filer/USAddress/ZIPCd098683
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId04CCB740526531868A34FE8FF5AF2B60C31201022
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0147EFE2FAB7795A8C1C62040DFC65CCCB755CF00
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt064.88.174.3
ReturnHeader/FilingSecurityInformation/IPDt02018-06-06
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0PD
ReturnHeader/FilingSecurityInformation/IPTm014:46:02
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0453960543
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0DILORENZO & COMPANY LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt010300 SW GREENBURG RD SUITE 360
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PORTLAND
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0OR
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd097223
ReturnHeader/PreparerPersonGrp/PhoneNum05036466696
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0KRIPA RAGURAM
ReturnHeader/ReturnTs02018-06-11T18:37:10-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02017-01-01
ReturnHeader/TaxPeriodEndDt02017-12-31
ReturnHeader/TaxYr02017

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$134,222
Liabilities
$0
Net assets
$134,222
Revenue
$87,372
Expenses
$21,292
Net income
$66,080
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.08$0.08$0.25$0.25$0.00
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.08$0.08$0.23$0.24$0.01
2022Detailed filing. Detailed filing data is available for this year.$0.09$0.09$0.26$0.88$0.62
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.71$0.71$1.39$2.40$1.00
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.71$1.71$1.37$0.64$0.73
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.98$0.98$1.54$1.67$0.13
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.11$1.11$0.93$1.16$0.23
2017Detailed filing. Detailed filing data is available for this year.$1.34$0.00$1.34$0.87$0.21$0.66
2016Detailed filing. Detailed filing data is available for this year.$0.68$0.00$0.68$0.54$0.06$0.47
2015Detailed filing. Detailed filing data is available for this year.$0.21$0.00$0.21$0.26$0.15$0.11
2014Detailed filing. Detailed filing data is available for this year.$0.11$0.00$0.11$0.16$0.10$0.06
2013Summary only. Only limited summary data is available for this year.$0.05$0.00$0.18$0.02$0.16